Balyasny Asset Management’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $2.84M | Sell |
|
|||||
|
2024
Q4 | $35.2M | Buy |
|
|||||
|
2024
Q3 | $29.3M | Buy |
|
|||||
|
2024
Q2 | $4.9M | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $2.63M | Buy |
|
|||||
|
2022
Q3 | $1.48M | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $440K | Buy |
|
|||||
|
2021
Q4 | $443K | Sell |
|
|||||
|
2021
Q3 | $1.2M | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $523K | Sell |
|
|||||
|
2020
Q3 | $8.35M | Buy |
|
|||||
|
2020
Q2 | $438K | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $5.17M | Buy |
|
|||||
|
2018
Q4 | – | Hold |
|
|||||
|
2018
Q3 | – | Hold |
|
|||||
|
2018
Q2 | – | Hold |
|